October 27, 2026- Instructions for Use (IFUs) are currently a hot topic in infection prevention circles. While IFUs serve a critical function by ensuring products are used safely and effectively, healthcare decision makers are increasingly scrutinizing whether manufacturer recommendations align with real-world clinical practice and evolving evidence-based guidance.
This conversation is particularly relevant for alcohol-based hand sanitizers (ABHS), where a key question is emerging: does the amount of sanitizer healthcare workers (HCWs) actually receive match the amount required to achieve the efficacy demonstrated in testing? Compounding the issue, the dose needed to effectively sanitize HCW hands is rarely included on a product label. Did you know that different brands of hand sanitizer, even those with the same level of alcohol, can reduce different amounts of bacteria on hands?
Look Beyond the Label
When evaluating hand sanitizers, healthcare decision makers should ask three important questions, which can be easily framed with “the 3D’s”:
- Delivery: Can the dispenser consistently deliver that dose?
- Data: Has the FDA required efficacy been demonstrated on skin?
- Dose: What volume of product was used to achieve those results?
Sponsored – Clorox Purell ProCare
Continue Reading in the latest issue of The Journal of Healthcare Contracting.